Home > Press > FEI Launches ‘Living Lab’ for Structural Biology Research at NIH: Official launch of Living Lab scientific program takes place May 23 on the NIH campus.
Abstract:
FEI (NASDAQ: FEIC), a scientific instruments company, marked the official launch of the new Living Lab for Structural Biology during an event on the NIH campus today.
FEI Launches ‘Living Lab’ for Structural Biology Research at NIH: Official launch of Living Lab scientific program takes place May 23 on the NIH campus.
Hillsboro, OR | Posted on May 23rd, 2012
"This event commences the FEI-NIH Living Lab joint scientific projects. FEI has installed the Titan Krios™ transmission electron microscope (TEM), the world's most powerful commercially-available electron microscope for structural biology, and our onsite team is assembled, including experts in sample preparation, cryo-electron microscopy applications, and Titan Krios operation. We are excited about this program and the great results we expect it will yield for the structural biology research community," stated FEI's President and CEO Dr. Don Kania.
The multi-faceted research program of the Living Lab at NIH includes participation from leading scientists, such as Dr. Sriram Subramaniam, director of the NIH component of the Living Lab, with expertise in cryo-electron microscopy and tomography; Drs. Adriaan Bax and G. Marius Clore, with expertise in NMR spectroscopy; Drs. Fred Dyda and Alex Wlodawer, with expertise in X-ray crystallography; and Drs. Suresh Ambudkar and Stuart Le Grice, with expertise in biochemistry. The capabilities of the Titan Krios for advanced cryo-electron microscopy are expected to effectively complement the work being done at NIH with NMR spectroscopy and X-ray crystallography and help accelerate important medical discoveries relevant to global health challenges such as HIV/AIDS, diabetes and cancer.
For more information about the Living Lab, please go to: www.fei.com/company/living-lab.aspx .
####
About FEI Company
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron- and ion-beam microscopes and solutions for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). Headquartered in Hillsboro, Ore., USA, FEI has over 2,200 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.
FEI Safe Harbor Statement
This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of the Living Lab for Structural Biology. Factors that could affect these forward-looking statements include but are not limited to: failure of the anticipated Living Lab collaboration to function as expected across multiple technologies to accelerate research and development on certain important life sciences issues; failure to manufacture, ship and deliver the tools or software as expected; other specific product or technology failures that could undermine the aims and outcomes of the collaboration; failure of the collaborative team to work together effectively; failure to develop the applications and software required for the collaboration to achieve its research goals or a change in assigned research personnel. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
For more information, please click here
Contacts:
Sandy Fewkes
(FEI media contact)
MindWrite Communications, Inc
+1 408 224 4024
Fletcher Chamberlin
(FEI investors and analysts)
Investor Relations
+1 503 726 7710
Copyright © FEI Company
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Peratech's new QTC Ultra Touch Screen technology goes behind the display so there is no light loss and longer battery life June 18th, 2013
Imaging
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Hitachi announces the SU8200 – a new type of cold field emitter SEM June 17th, 2013
Academic/Education
CNSE Welcomes Record Number of Students, Majority of Whom are New Yorkers, for Prestigious Summer Internship Program June 12th, 2013
FEI and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs: Collaboration effort will focus on new methods to classify shales in the economic assessment of “tight” resource plays June 7th, 2013
Johannes Gutenberg University Mainz obtains new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" June 2nd, 2013
Lorraine University uses Nanoparticle Tracking Analysis to characterize biomolecules for agrichemicals, pharmacology and cosmetics May 28th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Tools
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Beneq’s comprehensive industrial Thin Film Coating Services shorten time to market June 18th, 2013
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Events/Classes
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013